BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R, Medicine Society TM. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009;11:414-30. [PMID: 19891905 DOI: 10.1007/s11940-009-0046-0] [Cited by in Crossref: 187] [Cited by in F6Publishing: 164] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Franik S, Huidekoper HH, Visser G, de Vries M, de Boer L, Hermans-Peters M, Rodenburg R, Verhaak C, Vlieger AM, Smeitink JA, Janssen MC, Wortmann SB. High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders. J Inherit Metab Dis 2015;38:477-82. [PMID: 25303853 DOI: 10.1007/s10545-014-9773-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Danhauser K, Smeitink JAM, Freisinger P, Sperl W, Sabir H, Hadzik B, Mayatepek E, Morava E, Distelmaier F. Treatment options for lactic acidosis and metabolic crisis in children with mitochondrial disease. J Inherit Metab Dis 2015;38:467-75. [DOI: 10.1007/s10545-014-9796-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
3 Chen L, Cui Y, Jiang D, Ma C, Tse H, Hwu W, Lian Q. Management of Leigh syndrome: Current status and new insights. Clinical Genetics 2018;93:1131-40. [DOI: 10.1111/cge.13139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Santa KM. Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome. Pharmacotherapy 2010;30:1179-96. [PMID: 20973690 DOI: 10.1592/phco.30.11.1179] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
5 Rumore MM. Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks. J Pediatr Pharmacol Ther 2016;21:36-53. [PMID: 26997928 DOI: 10.5863/1551-6776-21.1.36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
6 Noorda G, van Achterberg T, van der Hooft T, Smeitink J, Schoonhoven L, van Engelen B. Problems of adults with a mitochondrial disease - the patients' perspective: focus on loss. JIMD Rep 2012;6:85-94. [PMID: 23430944 DOI: 10.1007/8904_2011_121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Marashly ET, Bohlega SA. Riboflavin Has Neuroprotective Potential: Focus on Parkinson's Disease and Migraine. Front Neurol 2017;8:333. [PMID: 28775706 DOI: 10.3389/fneur.2017.00333] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
8 Khan NA, Govindaraj P, Meena AK, Thangaraj K. Mitochondrial disorders: challenges in diagnosis & treatment. Indian J Med Res 2015;141:13-26. [PMID: 25857492 DOI: 10.4103/0971-5916.154489] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
9 DeBrosse C, Nanga RPR, Wilson N, D'Aquilla K, Elliott M, Hariharan H, Yan F, Wade K, Nguyen S, Worsley D, Parris-Skeete C, McCormick E, Xiao R, Cunningham ZZ, Fishbein L, Nathanson KL, Lynch DR, Stallings VA, Yudkoff M, Falk MJ, Reddy R, McCormack SE. Muscle oxidative phosphorylation quantitation using creatine chemical exchange saturation transfer (CrCEST) MRI in mitochondrial disorders. JCI Insight 2016;1:e88207. [PMID: 27812541 DOI: 10.1172/jci.insight.88207] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
10 Ehrenhaus Masotta N, Höcht C, Contin M, Lucangioli S, Rojas AM, Tripodi VP. Bioavailability of coenzyme Q10 loaded in an oleogel formulation for oral therapy: Comparison with a commercial-grade solid formulation. International Journal of Pharmaceutics 2020;582:119315. [DOI: 10.1016/j.ijpharm.2020.119315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sahoo S, Haraldsdóttir HS, Fleming RM, Thiele I. Modeling the effects of commonly used drugs on human metabolism. FEBS J 2015;282:297-317. [PMID: 25345908 DOI: 10.1111/febs.13128] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
12 Sabouny R, Wong R, Lee-Glover L, Greenway SC, Sinasac DS, Khan A, Shutt TE; Care4Rare Canada. Characterization of the C584R variant in the mtDNA depletion syndrome gene FBXL4, reveals a novel role for FBXL4 as a regulator of mitochondrial fusion. Biochim Biophys Acta Mol Basis Dis 2019;1865:165536. [PMID: 31442532 DOI: 10.1016/j.bbadis.2019.165536] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Sen K, Harrar D, Hahn A, Wells EM, Gropman AL. Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection. J Neurol 2021. [PMID: 33796896 DOI: 10.1007/s00415-021-10538-1] [Reference Citation Analysis]
14 Misrani A, Tabassum S, Yang L. Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease. Front Aging Neurosci 2021;13:617588. [PMID: 33679375 DOI: 10.3389/fnagi.2021.617588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Chae S, Kim SJ, Do Koo Y, Lee JH, Kim H, Ahn BY, Ha YC, Kim YH, Jang MG, Koo KH, Choi SH, Lim S, Park YJ, Jang HC, Hwang D, Lee SW, Park KS. A mitochondrial proteome profile indicative of type 2 diabetes mellitus in skeletal muscles. Exp Mol Med 2018;50:1-14. [PMID: 30266947 DOI: 10.1038/s12276-018-0154-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
16 Pepe S, Mentzer RM Jr, Gottlieb RA. Cell-permeable protein therapy for complex I dysfunction. J Bioenerg Biomembr 2014;46:337-45. [PMID: 25005682 DOI: 10.1007/s10863-014-9559-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Senger BA, Ward LD, Barbosa-leiker C, Bindler RC. Stress and coping of parents caring for a child with mitochondrial disease. Applied Nursing Research 2016;29:195-201. [DOI: 10.1016/j.apnr.2015.03.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
18 Lagler FB. Current and Emerging Therapies for Mitochondriopathies. Handb Exp Pharmacol 2020;261:57-65. [PMID: 31628601 DOI: 10.1007/164_2019_264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Radenkovic S, Bird MJ, Emmerzaal TL, Wong SY, Felgueira C, Stiers KM, Sabbagh L, Himmelreich N, Poschet G, Windmolders P, Verheijen J, Witters P, Altassan R, Honzik T, Eminoglu TF, James PM, Edmondson AC, Hertecant J, Kozicz T, Thiel C, Vermeersch P, Cassiman D, Beamer L, Morava E, Ghesquière B. The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG. Am J Hum Genet 2019;104:835-46. [PMID: 30982613 DOI: 10.1016/j.ajhg.2019.03.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
20 Chan F, Lax NZ, Davies CH, Turnbull DM, Cunningham MO. Neuronal oscillations: A physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases? Neuropharmacology 2016;102:48-58. [DOI: 10.1016/j.neuropharm.2015.10.033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
21 Jestin M, Kapnick SM, Tarasenko TN, Burke CT, Zerfas PM, Diaz F, Vernon H, Singh LN, Sokol RJ, McGuire PJ. Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity. Mol Metab 2020;37:100981. [PMID: 32283081 DOI: 10.1016/j.molmet.2020.100981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mercimek-mahmutoglu S, Cordeiro D, Cruz V, Hyland K, Struys EA, Kyriakopoulou L, Mamak E. Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: l-arginine supplementation alternative to lysine-restricted diet. European Journal of Paediatric Neurology 2014;18:741-6. [DOI: 10.1016/j.ejpn.2014.07.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
23 Khatter S, Puri RD, Bijarnia-mahay S, Aggarwal M, Ramprasad V, Saxena R, Verma IC. Sengers syndrome in Asian Indians – two novel mutations and variant phenotype-genotype correlation. TRD 2017;2:157-64. [DOI: 10.3233/trd-170017] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 McCormick EM, Kenyon L, Falk MJ. Desmin common mutation is associated with multi-systemic disease manifestations and depletion of mitochondria and mitochondrial DNA. Front Genet 2015;6:199. [PMID: 26097489 DOI: 10.3389/fgene.2015.00199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
25 Marsella CP, Taslim NA, Syam N, Syauki AY. Medical nutrition therapy in hemodynamically unstable patients due to cardiogenic shock with infected bronchiectasis and severe protein-energy malnutrition. Gac Sanit 2021;35 Suppl 2:S506-9. [PMID: 34929887 DOI: 10.1016/j.gaceta.2021.10.081] [Reference Citation Analysis]
26 Falk MJ. Neurodevelopmental manifestations of mitochondrial disease. J Dev Behav Pediatr 2010;31:610-21. [PMID: 20814259 DOI: 10.1097/DBP.0b013e3181ef42c1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
27 Seo GH, Oh A, Kim EN, Lee Y, Park J, Kim T, Lim YM, Kim GH, Kim CJ, Yoo HW, Kang E, Lee BH. Identification of extremely rare mitochondrial disorders by whole exome sequencing. J Hum Genet 2019;64:1117-25. [PMID: 31451716 DOI: 10.1038/s10038-019-0660-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
28 Swarnakar NK, Jain AK, Singh RP, Godugu C, Das M, Jain S. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials 2011;32:6860-74. [DOI: 10.1016/j.biomaterials.2011.05.079] [Cited by in Crossref: 107] [Cited by in F6Publishing: 87] [Article Influence: 9.7] [Reference Citation Analysis]
29 Mazunin IO, Volodko NV, Starikovskaya EB, Sukernik RI. Mitochondrial genome and human mitochondrial diseases. Mol Biol 2010;44:665-81. [DOI: 10.1134/s0026893310050018] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
30 Mehanna R, Itin I. Which Approach is Better: Bilateral Versus Unilateral Thalamic Deep Brain Stimulation in Patients with Fragile X–Associated Tremor Ataxia Syndrome. Cerebellum 2014;13:222-5. [DOI: 10.1007/s12311-013-0530-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
31 Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726 [PMID: 34904040 DOI: 10.4254/wjh.v13.i11.1707] [Reference Citation Analysis]
32 Peng M, Ostrovsky J, Kwon YJ, Polyak E, Licata J, Tsukikawa M, Marty E, Thomas J, Felix CA, Xiao R, Zhang Z, Gasser DL, Argon Y, Falk MJ. Inhibiting cytosolic translation and autophagy improves health in mitochondrial disease. Hum Mol Genet 2015;24:4829-47. [PMID: 26041819 DOI: 10.1093/hmg/ddv207] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
33 Ben-Shachar D, Ene HM. Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders? Biol Psychiatry 2018;83:770-9. [PMID: 28965983 DOI: 10.1016/j.biopsych.2017.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
34 Guha S, Mathew ND, Konkwo C, Ostrovsky J, Kwon YJ, Polyak E, Seiler C, Bennett M, Xiao R, Zhang Z, Nakamaru-Ogiso E, Falk MJ. Combinatorial glucose, nicotinic acid and N-acetylcysteine therapy has synergistic effect in preclinical C. elegans and zebrafish models of mitochondrial complex I disease. Hum Mol Genet 2021;30:536-51. [PMID: 33640978 DOI: 10.1093/hmg/ddab059] [Reference Citation Analysis]
35 Falk MJ, Polyak E, Zhang Z, Peng M, King R, Maltzman JS, Okwuego E, Horyn O, Nakamaru-Ogiso E, Ostrovsky J, Xie LX, Chen JY, Marbois B, Nissim I, Clarke CF, Gasser DL. Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice. EMBO Mol Med 2011;3:410-27. [PMID: 21567994 DOI: 10.1002/emmm.201100149] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
36 Chang JC, Liu KH, Chuang CS, Su HL, Wei YH, Kuo SJ, Liu CS. Treatment of human cells derived from MERRF syndrome by peptide-mediated mitochondrial delivery. Cytotherapy 2013;15:1580-96. [PMID: 24199594 DOI: 10.1016/j.jcyt.2013.06.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
37 Ha HK, Lee MR, Lee WJ. Bioaccessibility of β-Lactoglobulin Nanoemulsions Containing Coenzyme Q10: Impact of Droplet Size on the Bioaccessibility of Coenzyme Q10. Korean J Food Sci Anim Resour 2018;38:1294-304. [PMID: 30675122 DOI: 10.5851/kosfa.2018.e65] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
38 Senger BA, Ward LD, Barbosa-leiker C, Bindler RC. The Parent Experience of Caring for a Child with Mitochondrial Disease. Journal of Pediatric Nursing 2016;31:32-41. [DOI: 10.1016/j.pedn.2015.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
39 Suárez-Rivero JM, Villanueva-Paz M, de la Cruz-Ojeda P, de la Mata M, Cotán D, Oropesa-Ávila M, de Lavera I, Álvarez-Córdoba M, Luzón-Hidalgo R, Sánchez-Alcázar JA. Mitochondrial Dynamics in Mitochondrial Diseases. Diseases 2016;5:E1. [PMID: 28933354 DOI: 10.3390/diseases5010001] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 12.8] [Reference Citation Analysis]
40 Wang Y, Hekimi S. Micellization of coenzyme Q by the fungicide caspofungin allows for safe intravenous administration to reach extreme supraphysiological concentrations. Redox Biol 2020;36:101680. [PMID: 32810741 DOI: 10.1016/j.redox.2020.101680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
41 Delavallée L, Mathiah N, Cabon L, Mazeraud A, Brunelle-Navas MN, Lerner LK, Tannoury M, Prola A, Moreno-Loshuertos R, Baritaud M, Vela L, Garbin K, Garnier D, Lemaire C, Langa-Vives F, Cohen-Salmon M, Fernández-Silva P, Chrétien F, Migeotte I, Susin SA. Mitochondrial AIF loss causes metabolic reprogramming, caspase-independent cell death blockade, embryonic lethality, and perinatal hydrocephalus. Mol Metab 2020;40:101027. [PMID: 32480041 DOI: 10.1016/j.molmet.2020.101027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
42 Fiedorczuk K, Sazanov LA. Mammalian Mitochondrial Complex I Structure and Disease-Causing Mutations. Trends Cell Biol 2018;28:835-67. [PMID: 30055843 DOI: 10.1016/j.tcb.2018.06.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 13.3] [Reference Citation Analysis]
43 Gentili M, Raud C, Enel D, Hénot M, Bothereau H. Combination of general anaesthesia and postoperative epidural analgesia in mitochondrial myopathy. Annales Françaises d'Anesthésie et de Réanimation 2013;32:e149. [DOI: 10.1016/j.annfar.2013.07.798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 Mensch A, Zierz S. Cellular Stress in the Pathogenesis of Muscular Disorders-From Cause to Consequence. Int J Mol Sci 2020;21:E5830. [PMID: 32823799 DOI: 10.3390/ijms21165830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Falk MJ. The pursuit of precision mitochondrial medicine: Harnessing preclinical cellular and animal models to optimize mitochondrial disease therapeutic discovery. J Inherit Metab Dis 2021;44:312-24. [PMID: 33006762 DOI: 10.1002/jimd.12319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
46 Ghareghani M, Scavo L, Jand Y, Farhadi N, Sadeghi H, Ghanbari A, Mondello S, Arnoult D, Gharaghani S, Zibara K. Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis. Front Pharmacol 2019;10:147. [PMID: 30873027 DOI: 10.3389/fphar.2019.00147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
47 Fan HC, Lee HF, Yue CT, Chi CS. Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. Life (Basel) 2021;11:1111. [PMID: 34832987 DOI: 10.3390/life11111111] [Reference Citation Analysis]
48 Salminen TS, Cannino G, Oliveira MT, Lillsunde P, Jacobs HT, Kaguni LS. Lethal Interaction of Nuclear and Mitochondrial Genotypes in Drosophila melanogaster. G3 (Bethesda) 2019;9:2225-34. [PMID: 31076384 DOI: 10.1534/g3.119.400315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Na JH, Kim HD, Lee YM. Effective and safe diet therapies for Lennox-Gastaut syndrome with mitochondrial dysfunction. Ther Adv Neurol Disord 2020;13:1756286419897813. [PMID: 32082420 DOI: 10.1177/1756286419897813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Kuszak AJ, Espey MG, Falk MJ, Holmbeck MA, Manfredi G, Shadel GS, Vernon HJ, Zolkipli-Cunningham Z. Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems. Annu Rev Pathol 2018;13:163-91. [PMID: 29099651 DOI: 10.1146/annurev-pathol-020117-043644] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
51 Bax K, Isackson PJ, Moore M, Ambrus JL Jr. Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice. Curr Rheumatol Rep 2020;22:8. [PMID: 32067119 DOI: 10.1007/s11926-020-0879-9] [Reference Citation Analysis]
52 Inczedy-Farkas G, Remenyi V, Gal A, Varga Z, Balla P, Udvardy-Meszaros A, Bereznai B, Molnar MJ. Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behav Brain Funct 2012;8:9. [PMID: 22329956 DOI: 10.1186/1744-9081-8-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
53 Golubnitschaja O, Liskova A, Koklesova L, Samec M, Biringer K, Büsselberg D, Podbielska H, Kunin AA, Evsevyeva ME, Shapira N, Paul F, Erb C, Dietrich DE, Felbel D, Karabatsiakis A, Bubnov R, Polivka J, Polivka J Jr, Birkenbihl C, Fröhlich H, Hofmann-Apitius M, Kubatka P. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021. EPMA J 2021;:1-22. [PMID: 34422142 DOI: 10.1007/s13167-021-00251-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
54 Codier D, Codier E. Long-term central IV access in patients with mitochondrial disease. Br J Nurs 2014;23:S18-20, S22, S24. [PMID: 24763270 DOI: 10.12968/bjon.2014.23.Sup8.S18] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Arora A, Behl T, Sehgal A, Singh S, Sharma N, Mathew B, Bungau S. Targeting cellular batteries for the therapy of neurological diseases. Environ Sci Pollut Res Int 2021;28:41517-32. [PMID: 34080116 DOI: 10.1007/s11356-021-14665-0] [Reference Citation Analysis]
56 de Barcelos IP, Emmanuele V, Hirano M. Advances in primary mitochondrial myopathies. Curr Opin Neurol 2019;32:715-21. [PMID: 31408013 DOI: 10.1097/WCO.0000000000000743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Hroudová J, Fišar Z, Kitzlerová E, Zvěřová M, Raboch J. Mitochondrial respiration in blood platelets of depressive patients. Mitochondrion 2013;13:795-800. [DOI: 10.1016/j.mito.2013.05.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
58 Marín R, Chiarello DI, Abad C, Rojas D, Toledo F, Sobrevia L. Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia. Biochim Biophys Acta Mol Basis Dis 2020;1866:165961. [PMID: 32916282 DOI: 10.1016/j.bbadis.2020.165961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
59 Cree L, Loi P. Mitochondrial replacement: from basic research to assisted reproductive technology portfolio tool-technicalities and possible risks. Mol Hum Reprod 2015;21:3-10. [PMID: 25425606 DOI: 10.1093/molehr/gau082] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
60 Almannai M, Alfadhel M, El-Hattab AW. Carnitine Inborn Errors of Metabolism. Molecules 2019;24:E3251. [PMID: 31500110 DOI: 10.3390/molecules24183251] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
61 Siempos II, Ma KC, Imamura M, Baron RM, Fredenburgh LE, Huh JW, Moon JS, Finkelsztein EJ, Jones DS, Lizardi MT, Schenck EJ, Ryter SW, Nakahira K, Choi AM. RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury. JCI Insight 2018;3:97102. [PMID: 29720570 DOI: 10.1172/jci.insight.97102] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
62 Gardner A, Boles RG. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:730-43. [PMID: 20691744 DOI: 10.1016/j.pnpbp.2010.07.030] [Cited by in Crossref: 197] [Cited by in F6Publishing: 186] [Article Influence: 16.4] [Reference Citation Analysis]
63 Priliani L, Prado EL, Restuadi R, Waturangi DE, Shankar AH, Malik SG. Maternal Multiple Micronutrient Supplementation Stabilizes Mitochondrial DNA Copy Number in Pregnant Women in Lombok, Indonesia. J Nutr 2019;149:1309-16. [PMID: 31177276 DOI: 10.1093/jn/nxz064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
64 Ma C, Xia F, Kelley SO. Mitochondrial Targeting of Probes and Therapeutics to the Powerhouse of the Cell. Bioconjug Chem 2020;31:2650-67. [PMID: 33191743 DOI: 10.1021/acs.bioconjchem.0c00470] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
65 Cherix A, Larrieu T, Grosse J, Rodrigues J, McEwen B, Nasca C, Gruetter R, Sandi C. Metabolic signature in nucleus accumbens for anti-depressant-like effects of acetyl-L-carnitine. Elife 2020;9:e50631. [PMID: 31922486 DOI: 10.7554/eLife.50631] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 11.5] [Reference Citation Analysis]
66 Cohen BH, Naviaux RK. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Methods 2010;51:364-73. [DOI: 10.1016/j.ymeth.2010.05.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
67 Patananan AN, Wu TH, Chiou PY, Teitell MA. Modifying the Mitochondrial Genome. Cell Metab 2016;23:785-96. [PMID: 27166943 DOI: 10.1016/j.cmet.2016.04.004] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 15.0] [Reference Citation Analysis]
68 Conboy E, Selcen D, Brodsky M, Gavrilova R, Ho ML. Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype. Seminars in Pediatric Neurology 2018;26:16-20. [DOI: 10.1016/j.spen.2018.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
69 Teixeira J, Oliveira C, Cagide F, Amorim R, Garrido J, Borges F, Oliveira PJ. Discovery of a new mitochondria permeability transition pore (mPTP) inhibitor based on gallic acid. J Enzyme Inhib Med Chem 2018;33:567-76. [PMID: 29513043 DOI: 10.1080/14756366.2018.1442831] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
70 Gasparini CF, Sutherland HG, Griffiths LR. Studies on the pathophysiology and genetic basis of migraine. Curr Genomics 2013;14:300-15. [PMID: 24403849 DOI: 10.2174/13892029113149990007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
71 Granata S, Dalla Gassa A, Tomei P, Lupo A, Zaza G. Mitochondria: a new therapeutic target in chronic kidney disease. Nutr Metab (Lond) 2015;12:49. [PMID: 26612997 DOI: 10.1186/s12986-015-0044-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
72 Breed D, Meyer LCR, Steyl JCA, Goddard A, Burroughs R, Kohn TA. Conserving wildlife in a changing world: Understanding capture myopathy-a malignant outcome of stress during capture and translocation. Conserv Physiol 2019;7:coz027. [PMID: 31304016 DOI: 10.1093/conphys/coz027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
73 Hettiarachchi D, Lakmal K, Dissanayake VHW. Mitochondrial diseases in South Asia - A systematic review. Mitochondrion 2021;62:24-30. [PMID: 34740865 DOI: 10.1016/j.mito.2021.10.007] [Reference Citation Analysis]
74 Stefely JA, Pagliarini DJ. Biochemistry of Mitochondrial Coenzyme Q Biosynthesis. Trends Biochem Sci 2017;42:824-43. [PMID: 28927698 DOI: 10.1016/j.tibs.2017.06.008] [Cited by in Crossref: 109] [Cited by in F6Publishing: 91] [Article Influence: 21.8] [Reference Citation Analysis]
75 Jha MK, Lee IK, Suk K. Metabolic reprogramming by the pyruvate dehydrogenase kinase-lactic acid axis: Linking metabolism and diverse neuropathophysiologies. Neurosci Biobehav Rev 2016;68:1-19. [PMID: 27179453 DOI: 10.1016/j.neubiorev.2016.05.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
76 Barcelos I, Shadiack E, Ganetzky RD, Falk MJ. Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines. Curr Opin Pediatr 2020;32:707-18. [PMID: 33105273 DOI: 10.1097/MOP.0000000000000954] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
77 Zhang Z, Tsukikawa M, Peng M, Polyak E, Nakamaru-Ogiso E, Ostrovsky J, McCormack S, Place E, Clarke C, Reiner G, McCormick E, Rappaport E, Haas R, Baur JA, Falk MJ. Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling network. PLoS One 2013;8:e69282. [PMID: 23894440 DOI: 10.1371/journal.pone.0069282] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
78 Liskova A, Samec M, Koklesova L, Kudela E, Kubatka P, Golubnitschaja O. Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine. Int J Mol Sci 2021;22:2007. [PMID: 33670490 DOI: 10.3390/ijms22042007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
79 Cohen BH, Saneto RP. Mitochondrial translational inhibitors in the pharmacopeia. Biochim Biophys Acta 2012;1819:1067-74. [PMID: 22421540 DOI: 10.1016/j.bbagrm.2012.02.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
80 Niezgoda J, Morgan PG. Anesthetic considerations in patients with mitochondrial defects. Paediatr Anaesth. 2013;23:785-793. [PMID: 23534340 DOI: 10.1111/pan.12158] [Cited by in Crossref: 74] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
81 Udhaya Lavinya B, Bardhan I, Evan Prince S. Efficacy of CoenzymeQ10 in inhibiting monosodium urate crystal-induced inflammation in rats. European Journal of Pharmacology 2016;791:589-94. [DOI: 10.1016/j.ejphar.2016.09.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
82 Lin BY, Kao MC. Therapeutic applications of the TAT-mediated protein transduction system for complex I deficiency and other mitochondrial diseases. Ann N Y Acad Sci 2015;1350:17-28. [PMID: 26273800 DOI: 10.1111/nyas.12858] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
83 El-Hattab AW, Zarante AM, Almannai M, Scaglia F. Therapies for mitochondrial diseases and current clinical trials. Mol Genet Metab 2017;122:1-9. [PMID: 28943110 DOI: 10.1016/j.ymgme.2017.09.009] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 16.4] [Reference Citation Analysis]
84 Neergheen V, Chalasani A, Wainwright L, Yubero D, Montero R, Artuch R, Hargreaves I. Coenzyme Q 10 in the Treatment of Mitochondrial Disease. Journal of Inborn Errors of Metabolism and Screening 2017;5:232640981770777. [DOI: 10.1177/2326409817707771] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
85 Frye RE, Rossignol D, Casanova MF, Brown GL, Martin V, Edelson S, Coben R, Lewine J, Slattery JC, Lau C, Hardy P, Fatemi SH, Folsom TD, Macfabe D, Adams JB. A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel. Front Public Health 2013;1:31. [PMID: 24350200 DOI: 10.3389/fpubh.2013.00031] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
86 Murayama K, Shimura M, Liu Z, Okazaki Y, Ohtake A. Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases. J Hum Genet 2019;64:113-25. [PMID: 30459337 DOI: 10.1038/s10038-018-0528-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
87 Di Stadio A, Angelini C. Microglia polarization by mitochondrial metabolism modulation: A therapeutic opportunity in neurodegenerative diseases. Mitochondrion 2019;46:334-6. [PMID: 30243831 DOI: 10.1016/j.mito.2018.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
88 Ducharlet K, Thyagarajan D, Ierino F, McMahon LP, Lee D. Perioperative risk assessment for successful kidney transplant in leigh syndrome: a case report. BMC Nephrol 2018;19:23. [PMID: 29390978 DOI: 10.1186/s12882-018-0816-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Gurrieri C, Kivela JE, Bojanić K, Gavrilova RH, Flick RP, Sprung J, Weingarten TN. Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series. Can J Anaesth 2011;58:751-63. [PMID: 21656321 DOI: 10.1007/s12630-011-9528-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
90 Kramer P, Bressan P. Our (Mother's) Mitochondria and Our Mind. Perspect Psychol Sci 2018;13:88-100. [PMID: 28937858 DOI: 10.1177/1745691617718356] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
91 Lilitsis E, Astyrakaki E, Blevrakis E, Xenaki S, Chalkiadakis G, Chrysos E. Anesthetic management of a pediatric patient with Electron Transfer Flavoprotein Dehydrogenase deficiency (ETFDH) and acute appendicitis: case report and review of the literature. BMC Anesthesiol 2017;17:116. [PMID: 28851284 DOI: 10.1186/s12871-017-0400-9] [Reference Citation Analysis]
92 Lehmann D, Mcfarland R. Overview of Approaches to Mitochondrial Disease Therapy. Journal of Inborn Errors of Metabolism and Screening 2018;6:232640981775296. [DOI: 10.1177/2326409817752960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
93 Napoli E, Dueñas N, Giulivi C. Potential therapeutic use of the ketogenic diet in autism spectrum disorders. Front Pediatr 2014;2:69. [PMID: 25072037 DOI: 10.3389/fped.2014.00069] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
94 Bennett CF, Ronayne CT, Puigserver P. Targeting adaptive cellular responses to mitochondrial bioenergetic deficiencies in human disease. FEBS J 2021. [PMID: 34510753 DOI: 10.1111/febs.16195] [Reference Citation Analysis]
95 Zolkipli-Cunningham Z, Xiao R, Stoddart A, McCormick EM, Holberts A, Burrill N, McCormack S, Williams L, Wang X, Thompson JLP, Falk MJ. Mitochondrial disease patient motivations and barriers to participate in clinical trials. PLoS One 2018;13:e0197513. [PMID: 29771953 DOI: 10.1371/journal.pone.0197513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
96 Ino D, Iino M. Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons. Cell Mol Life Sci 2017;74:827-35. [PMID: 27638763 DOI: 10.1007/s00018-016-2364-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
97 Rai PK, Russell OM, Lightowlers RN, Turnbull DM. Potential compounds for the treatment of mitochondrial disease. Br Med Bull 2015;116:5-18. [PMID: 26590387 DOI: 10.1093/bmb/ldv046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
98 Fullerton M, McFarland R, Taylor RW, Alston CL. The genetic basis of isolated mitochondrial complex II deficiency. Mol Genet Metab 2020;131:53-65. [PMID: 33162331 DOI: 10.1016/j.ymgme.2020.09.009] [Reference Citation Analysis]
99 Haas A, Wappler F. [Characteristics of anesthesia in patients with MELAS syndrome: Case report of anesthesia in video-assisted thoracoscopy]. Anaesthesist 2015;64:747-53. [PMID: 26314741 DOI: 10.1007/s00101-015-0075-x] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
100 Zhou C, Wang J, Zhang Q, Yang Q, Yi S, Shen Y, Luo J, Qin Z. Clinical and genetic analysis of combined oxidative phosphorylation defificiency-10 caused by MTO1 mutation. Clin Chim Acta 2022:S0009-8981(21)00454-X. [PMID: 34990597 DOI: 10.1016/j.cca.2021.12.025] [Reference Citation Analysis]
101 Zekonyte U, Bacman SR, Moraes CT. DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases. J Intern Med 2020;287:685-97. [PMID: 32176378 DOI: 10.1111/joim.13055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
102 García-Corzo L, Luna-Sánchez M, Doerrier C, Ortiz F, Escames G, Acuña-Castroviejo D, López LC. Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency. Biochim Biophys Acta 2014;1842:893-901. [PMID: 24576561 DOI: 10.1016/j.bbadis.2014.02.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
103 Swarnakar NK, Thanki K, Jain S. Lyotropic Liquid Crystalline Nanoparticles of CoQ10: Implication of Lipase Digestibility on Oral Bioavailability, in Vivo antioxidant activity, and in Vitroin Vivo Relationships. Mol Pharmaceutics 2014;11:1435-49. [DOI: 10.1021/mp400601g] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
104 Rucklidge JJ, Kaplan BJ. Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Review of Neurotherapeutics 2014;13:49-73. [DOI: 10.1586/ern.12.143] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
105 Oishi K, Arnon R, Wasserstein MP, Diaz GA. Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management. Pediatr Transplant 2016;20:756-69. [PMID: 27329540 DOI: 10.1111/petr.12741] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
106 Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R; Mitochondrial Medicine Society Clinical Directors Working Group., Clinical Director's Work Group. Practice patterns of mitochondrial disease physicians in North America. Part 2: treatment, care and management. Mitochondrion 2013;13:681-7. [PMID: 24063850 DOI: 10.1016/j.mito.2013.09.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
107 Weiss JN, Levy S, Benes SC. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy. Neural Regen Res 2016;11:1685-94. [PMID: 27904503 DOI: 10.4103/1673-5374.193251] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
108 Abu-Serie MM, El-Gamal BA, El-Kersh MA, El-Saadani MA. Investigation into the antioxidant role of arginine in the treatment and the protection for intralipid-induced non-alcoholic steatohepatitis. Lipids Health Dis 2015;14:128. [PMID: 26463841 DOI: 10.1186/s12944-015-0124-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
109 Limongelli G, Masarone D, Pacileo G. Mitochondrial disease and the heart. Heart 2017;103:390-8. [PMID: 27821705 DOI: 10.1136/heartjnl-2015-308193] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
110 Masotta NE, Martinefski MR, Lucangioli S, Rojas AM, Tripodi VP. High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation. International Journal of Pharmaceutics 2019;556:9-20. [DOI: 10.1016/j.ijpharm.2018.12.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
111 García-García FJ, Monistrol-Mula A, Cardellach F, Garrabou G. Nutrition, Bioenergetics, and Metabolic Syndrome. Nutrients 2020;12:E2785. [PMID: 32933003 DOI: 10.3390/nu12092785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
112 Gardner A, Boles RG. Comment on Treatment of Psychiatric Illness in Patients with Mitochondrial Disease. Psychosomatics 2011;52:497-8. [DOI: 10.1016/j.psym.2011.01.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
113 Amdani SM, Kim HS, Orvedahl A, John AO, Said A, Simpson K. Successful treatment of fulminant neonatal enteroviral myocarditis in monochorionic diamniotic twins with cardiopulmonary support, intravenous immunoglobulin and pocapavir. BMJ Case Rep 2018;2018:bcr-2017-224133. [PMID: 29776940 DOI: 10.1136/bcr-2017-224133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
114 Koňaříková E, Marković A, Korandová Z, Houštěk J, Mráček T. Current progress in the therapeutic options for mitochondrial disorders. Physiol Res 2020;69:967-94. [PMID: 33129249 DOI: 10.33549/physiolres.934529] [Reference Citation Analysis]
115 Mancuso M, Orsucci D, Filosto M, Simoncini C, Siciliano G. Drugs and mitochondrial diseases: 40 queries and answers. Expert Opinion on Pharmacotherapy 2012;13:527-43. [DOI: 10.1517/14656566.2012.657177] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
116 Jackson CB, Hahn D, Schröter B, Richter U, Battersby BJ, Schmitt-Mechelke T, Marttinen P, Nuoffer JM, Schaller A. A novel mitochondrial ATP6 frameshift mutation causing isolated complex V deficiency, ataxia and encephalomyopathy. Eur J Med Genet 2017;60:345-51. [PMID: 28412374 DOI: 10.1016/j.ejmg.2017.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
117 Polyak E, Ostrovsky J, Peng M, Dingley SD, Tsukikawa M, Kwon YJ, McCormack SE, Bennett M, Xiao R, Seiler C, Zhang Z, Falk MJ. N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease. Mol Genet Metab 2018;123:449-62. [PMID: 29526616 DOI: 10.1016/j.ymgme.2018.02.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
118 Fukuda M, Nagao Y. Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report. J Med Case Rep 2019;13:313. [PMID: 31630688 DOI: 10.1186/s13256-019-2255-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
119 Purhonen J, Rajendran J, Mörgelin M, Uusi-Rauva K, Katayama S, Krjutskov K, Einarsdottir E, Velagapudi V, Kere J, Jauhiainen M, Fellman V, Kallijärvi J. Ketogenic diet attenuates hepatopathy in mouse model of respiratory chain complex III deficiency caused by a Bcs1l mutation. Sci Rep 2017;7:957. [PMID: 28424480 DOI: 10.1038/s41598-017-01109-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
120 Muraresku CC, McCormick EM, Falk MJ. Mitochondrial Disease: Advances in clinical diagnosis, management, therapeutic development, and preventative strategies. Curr Genet Med Rep 2018;6:62-72. [PMID: 30393588 DOI: 10.1007/s40142-018-0138-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
121 Farruggia P, Di Marco F, Dufour C. Pearson syndrome. Expert Rev Hematol 2018;11:239-46. [PMID: 29337599 DOI: 10.1080/17474086.2018.1426454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
122 Kuthethur R, Prasad K, Chakrabarty S, Kabekkodu SP, Singh KK, Thangaraj K, Satyamoorthy K. Advances in mitochondrial medicine and translational research. Mitochondrion 2021;61:62-8. [PMID: 34571249 DOI: 10.1016/j.mito.2021.09.008] [Reference Citation Analysis]
123 Murphy MP, Hartley RC. Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discov 2018;17:865-86. [PMID: 30393373 DOI: 10.1038/nrd.2018.174] [Cited by in Crossref: 211] [Cited by in F6Publishing: 203] [Article Influence: 52.8] [Reference Citation Analysis]
124 Byrnes J, Ganetzky R, Lightfoot R, Tzeng M, Nakamaru-Ogiso E, Seiler C, Falk MJ. Pharmacologic modeling of primary mitochondrial respiratory chain dysfunction in zebrafish. Neurochem Int 2018;117:23-34. [PMID: 28732770 DOI: 10.1016/j.neuint.2017.07.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
125 Khdour OM, Lu J, Hecht SM. An Acetate Prodrug of a Pyridinol-Based Vitamin E Analogue. Pharm Res 2011;28:2896-909. [DOI: 10.1007/s11095-011-0491-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
126 Pastor-Maldonado CJ, Suárez-Rivero JM, Povea-Cabello S, Álvarez-Córdoba M, Villalón-García I, Munuera-Cabeza M, Suárez-Carrillo A, Talaverón-Rey M, Sánchez-Alcázar JA. Coenzyme Q10: Novel Formulations and Medical Trends. Int J Mol Sci 2020;21:E8432. [PMID: 33182646 DOI: 10.3390/ijms21228432] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
127 M King W, Kissel JT. Multidisciplinary approach to the management of myopathies. Continuum (Minneap Minn) 2013;19:1650-73. [PMID: 24305452 DOI: 10.1212/01.CON.0000440664.34051.4d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
128 Behjati M, Sabri MR, Etemadi Far M, Nejati M. Cardiac complications in inherited mitochondrial diseases. Heart Fail Rev 2021;26:391-403. [PMID: 32728985 DOI: 10.1007/s10741-020-10009-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Yeoh C, Teng H, Jackson J, Hingula L, Irie T, Legler A, Levine C, Chu I, Chai C, Tollinche L. Metabolic Disorders and Anesthesia. Curr Anesthesiol Rep 2019;9:340-59. [PMID: 31406490 DOI: 10.1007/s40140-019-00345-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Branco AF, Ferreira A, Simões RF, Magalhães-novais S, Zehowski C, Cope E, Silva AM, Pereira D, Sardão VA, Cunha-oliveira T. Ketogenic diets: from cancer to mitochondrial diseases and beyond. Eur J Clin Invest 2016;46:285-98. [DOI: 10.1111/eci.12591] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 11.7] [Reference Citation Analysis]
131 Kuthethur R, Prasad K, Chakrabarty S, Prasada Kabekkodu S, Singh KK, Thangaraj K, Satyamoorthy K. Advances in Mitochondrial Medicine and Translational Research. Mitochondrion 2021:S1567-7249(21)00102-1. [PMID: 34363984 DOI: 10.1016/j.mito.2021.08.001] [Reference Citation Analysis]
132 Chidambaram SB, Bhat A, Mahalakshmi AM, Ray B, Tuladhar S, Sushmitha BS, Saravanan B, Thamilarasan M, Thenmozhi AJ, Essa MM, Guillemin GJ, Qoronfleh MW. Protein Nutrition in Autism. Adv Neurobiol 2020;24:573-86. [PMID: 32006374 DOI: 10.1007/978-3-030-30402-7_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
133 Rucklidge JJ, Kaplan BJ. Broad-spectrum micronutrient treatment for attention-deficit/hyperactivity disorder: rationale and evidence to date. CNS Drugs 2014;28:775-85. [PMID: 25056569 DOI: 10.1007/s40263-014-0190-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
134 Finsterer J. Clinical Therapeutic Management of Human Mitochondrial Disorders. Pediatric Neurology 2020;113:66-74. [DOI: 10.1016/j.pediatrneurol.2020.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Mellon SH, Gautam A, Hammamieh R, Jett M, Wolkowitz OM. Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder. Biological Psychiatry 2018;83:866-75. [DOI: 10.1016/j.biopsych.2018.02.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 14.8] [Reference Citation Analysis]
136 Polyak E, Zhang Z, Falk MJ. Molecular profiling of mitochondrial dysfunction in Caenorhabditis elegans. Methods Mol Biol 2012;837:241-55. [PMID: 22215553 DOI: 10.1007/978-1-61779-504-6_17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
137 Villanueva Paz M, Cotán D, Garrido-Maraver J, Cordero MD, Oropesa-Ávila M, de La Mata M, Delgado Pavón A, de Lavera I, Alcocer-Gómez E, Sánchez-Alcázar JA. Targeting autophagy and mitophagy for mitochondrial diseases treatment. Expert Opin Ther Targets 2016;20:487-500. [PMID: 26523761 DOI: 10.1517/14728222.2016.1101068] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
138 Wojtala A, Karkucinska-Wieckowska A, Sardao VA, Szczepanowska J, Kowalski P, Pronicki M, Duszynski J, Wieckowski MR. Modulation of mitochondrial dysfunction-related oxidative stress in fibroblasts of patients with Leigh syndrome by inhibition of prooxidative p66Shc pathway. Mitochondrion 2017;37:62-79. [PMID: 28739512 DOI: 10.1016/j.mito.2017.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
139 Ticci C, Orsucci D, Ardissone A, Bello L, Bertini E, Bonato I, Bruno C, Carelli V, Diodato D, Doccini S, Donati MA, Dosi C, Filosto M, Fiorillo C, La Morgia C, Lamperti C, Marchet S, Martinelli D, Minetti C, Moggio M, Mongini TE, Montano V, Moroni I, Musumeci O, Pancheri E, Pegoraro E, Primiano G, Procopio E, Rubegni A, Scalise R, Sciacco M, Servidei S, Siciliano G, Simoncini C, Tolomeo D, Tonin P, Toscano A, Tubili F, Mancuso M, Battini R, Santorelli FM. Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases. J Clin Med 2021;10:2063. [PMID: 34065803 DOI: 10.3390/jcm10102063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Gueguen N, Baris O, Lenaers G, Reynier P, Spinazzi M. Secondary coenzyme Q deficiency in neurological disorders. Free Radical Biology and Medicine 2021;165:203-18. [DOI: 10.1016/j.freeradbiomed.2021.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Uziel G, Ghezzi D, Zeviani M. Infantile mitochondrial encephalopathy. Semin Fetal Neonatal Med. 2011;16:205-215. [PMID: 21620787 DOI: 10.1016/j.siny.2011.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
142 Ganetzky RD, Cuddapah SR. Neonatal Lactic Acidosis: A Diagnostic and Therapeutic Approach. Neoreviews 2017;18:e217-27. [DOI: 10.1542/neo.18-4-e217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
143 Niedermayr K, Pölzl G, Scholl‐bürgi S, Fauth C, Schweigmann U, Haberlandt E, Albrecht U, Zlamy M, Sperl W, Mayr JA, Karall D. Mitochondrial DNA mutation “m.3243A>G”—Heterogeneous clinical picture for cardiologists (“m.3243A>G”: A phenotypic chameleon). Congenital Heart Disease 2018;13:671-7. [DOI: 10.1111/chd.12634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
144 Tischner C, Wenz T. Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders. Mitochondrion 2015;24:32-49. [DOI: 10.1016/j.mito.2015.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
145 Yeung RO, Hannah-Shmouni F, Niederhoffer K, Walker MA. Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes. Rev Endocr Metab Disord 2018;19:35-52. [PMID: 29777474 DOI: 10.1007/s11154-018-9446-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
146 Zhang L, Zhang Z, Khan A, Zheng H, Yuan C, Jiang H. Advances in drug therapy for mitochondrial diseases. Ann Transl Med 2020;8:17. [PMID: 32055608 DOI: 10.21037/atm.2019.10.113] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
147 Stuart S, Griffiths LR. A possible role for mitochondrial dysfunction in migraine. Mol Genet Genomics 2012;287:837-44. [DOI: 10.1007/s00438-012-0723-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
148 Govers LP, Toka HR, Hariri A, Walsh SB, Bockenhauer D. Mitochondrial DNA mutations in renal disease: an overview. Pediatr Nephrol 2021;36:9-17. [PMID: 31925537 DOI: 10.1007/s00467-019-04404-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
149 Ahuja AS. Understanding mitochondrial myopathies: a review. PeerJ 2018;6:e4790. [PMID: 29844960 DOI: 10.7717/peerj.4790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
150 Cohen B, Balcells C, Hotchkiss B, Aggarwal K, Karaa A. A retrospective analysis of health care utilization for patients with mitochondrial disease in the United States: 2008-2015. Orphanet J Rare Dis 2018;13:210. [PMID: 30466460 DOI: 10.1186/s13023-018-0949-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Smeltzer SC, Wint AJ, Ecker JL, Iezzoni LI. Labor, delivery, and anesthesia experiences of women with physical disability. Birth 2017;44:315-24. [PMID: 28594070 DOI: 10.1111/birt.12296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Boles RG. High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series. BMC Neurol 2011;11:102. [PMID: 21846334 DOI: 10.1186/1471-2377-11-102] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
153 Avula S, Parikh S, Demarest S, Kurz J, Gropman A. Treatment of mitochondrial disorders. Curr Treat Options Neurol 2014;16:292. [PMID: 24700433 DOI: 10.1007/s11940-014-0292-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
154 Karaa A, Kriger J, Grier J, Holbert A, Thompson JL, Parikh S, Hirano M. Mitochondrial disease patients' perception of dietary supplements' use. Mol Genet Metab 2016;119:100-8. [PMID: 27444792 DOI: 10.1016/j.ymgme.2016.07.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
155 Enns GM. Treatment of mitochondrial disorders: antioxidants and beyond. J Child Neurol 2014;29:1235-40. [PMID: 24985754 DOI: 10.1177/0883073814538509] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
156 Ugwu N, Ikeri K, Goenka S, Menkiti O. Case 1: Case of Lactic Acidosis in a Term Neonate. Neoreviews 2021;22:e52-4. [PMID: 33386314 DOI: 10.1542/neo.22-1-e52] [Reference Citation Analysis]
157 Foriel S, Beyrath J, Eidhof I, Rodenburg RJ, Schenck A, Smeitink JAM. Feeding difficulties, a key feature of the Drosophila NDUFS4 mitochondrial disease model. Dis Model Mech 2018;11:dmm032482. [PMID: 29590638 DOI: 10.1242/dmm.032482] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
158 Galán F, de Lavera I, Cotán D, Sánchez-Alcázar JA. Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome. J Investig Med High Impact Case Rep 2015;3:2324709615607908. [PMID: 26904705 DOI: 10.1177/2324709615607908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
159 Burelle Y, Bemeur C, Rivard ME, Thompson Legault J, Boucher G, Morin C, Coderre L, Des Rosiers C; LSFC Consortium. Mitochondrial vulnerability and increased susceptibility to nutrient-induced cytotoxicity in fibroblasts from leigh syndrome French canadian patients. PLoS One 2015;10:e0120767. [PMID: 25835550 DOI: 10.1371/journal.pone.0120767] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
160 Abdin A, Sarhan N. Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity. Can J Physiol Pharmacol 2014;92:780-8. [PMID: 25162205 DOI: 10.1139/cjpp-2014-0251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
161 Homan DJ, Niyazov DM, Fisher PW, Mandras S, Patel H, Bates M, Parrino G, Ventura HO. Heart Transplantation for a Patient With Kearns-Sayre Syndrome and End-Stage Heart Failure: Kearns-Sayre syndrome and end-stage heart failure. Congestive Heart Failure 2011;17:101-3. [DOI: 10.1111/j.1751-7133.2011.00211.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
162 Saneto RP. Genetics of Mitochondrial Disease. Adv Genet 2017;98:63-116. [PMID: 28942795 DOI: 10.1016/bs.adgen.2017.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
163 Gruosso F, Montano V, Simoncini C, Siciliano G, Mancuso M. Therapeutical Management and Drug Safety in Mitochondrial Diseases-Update 2020. J Clin Med 2020;10:E94. [PMID: 33383961 DOI: 10.3390/jcm10010094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
164 Almannai M, El-Hattab AW, Ali M, Soler-Alfonso C, Scaglia F. Clinical trials in mitochondrial disorders, an update. Mol Genet Metab 2020;131:1-13. [PMID: 33129691 DOI: 10.1016/j.ymgme.2020.10.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
165 Reynolds E, Byrne M, Ganetzky R, Parikh S. Pediatric single large-scale mtDNA deletion syndromes: The power of patient reported outcomes. Mol Genet Metab 2021;134:301-8. [PMID: 34862134 DOI: 10.1016/j.ymgme.2021.11.004] [Reference Citation Analysis]
166 Goldenthal MJ. Mitochondrial involvement in myocyte death and heart failure. Heart Fail Rev 2016;21:137-55. [PMID: 26886225 DOI: 10.1007/s10741-016-9531-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
167 Molleston JP, Sokol RJ, Karnsakul W, Miethke A, Horslen S, Magee JC, Romero R, Squires RH, Van Hove JL. Evaluation of the child with suspected mitochondrial liver disease. J Pediatr Gastroenterol Nutr. 2013;57:269-276. [PMID: 23783016 DOI: 10.1097/mpg.0b013e31829ef67a] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
168 Tinker RJ, Lim AZ, Stefanetti RJ, McFarland R. Current and Emerging Clinical Treatment in Mitochondrial Disease. Mol Diagn Ther 2021;25:181-206. [PMID: 33646563 DOI: 10.1007/s40291-020-00510-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
169 Limongelli G, Masarone D, D’alessandro R, Elliott PM. Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. Future Cardiology 2012;8:71-88. [DOI: 10.2217/fca.11.79] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
170 Barbi E, Marzuillo P, Neri E, Naviglio S, Krauss BS. Fever in Children: Pearls and Pitfalls. Children (Basel) 2017;4:E81. [PMID: 28862659 DOI: 10.3390/children4090081] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
171 Ganetzky RD, Falk MJ. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease. Mol Genet Metab 2018;123:301-8. [PMID: 29428506 DOI: 10.1016/j.ymgme.2018.01.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
172 Goh S, Dong Z, Zhang Y, DiMauro S, Peterson BS. Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging. JAMA Psychiatry 2014;71:665-71. [PMID: 24718932 DOI: 10.1001/jamapsychiatry.2014.179] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 10.9] [Reference Citation Analysis]